Bio Green Med Solution, Inc. (BGMS)
0.836
+0.01
(+0.72%)
USD |
NASDAQ |
Oct 30, 10:07
Bio Green Med Solution Enterprise Value : 1.707M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 1.707M |
| October 28, 2026 | 2.304M |
| October 27, 2026 | 2.459M |
| October 26, 2026 | 2.518M |
| October 23, 2026 | 2.568M |
| October 22, 2026 | 2.461M |
| October 21, 2026 | 2.833M |
| October 20, 2026 | 2.435M |
| October 19, 2026 | 2.388M |
| October 16, 2026 | 2.232M |
| October 15, 2026 | 1.724M |
| October 14, 2026 | 2.134M |
| October 13, 2026 | 2.302M |
| October 12, 2026 | 2.767M |
| October 09, 2026 | 1.833M |
| October 08, 2026 | 1.647M |
| October 07, 2026 | 1.839M |
| October 06, 2026 | 1.877M |
| October 05, 2026 | 1.961M |
| October 02, 2026 | 2.038M |
| October 01, 2026 | 2.199M |
| September 30, 2026 | 2.052M |
| September 29, 2026 | 2.038M |
| September 28, 2026 | 2.194M |
| September 25, 2026 | 2.303M |
| Date | Value |
|---|---|
| September 24, 2026 | 2.468M |
| September 23, 2026 | 2.582M |
| September 22, 2026 | 2.354M |
| September 21, 2026 | 2.490M |
| September 18, 2026 | 2.416M |
| September 17, 2026 | 2.026M |
| September 16, 2026 | 2.768M |
| September 15, 2026 | 3.183M |
| September 14, 2026 | 2.155M |
| September 11, 2026 | 1.985M |
| September 10, 2026 | 1.807M |
| September 09, 2026 | 1.872M |
| September 08, 2026 | 1.992M |
| September 04, 2026 | 2.194M |
| September 03, 2026 | 2.314M |
| September 02, 2026 | 1.724M |
| September 01, 2026 | 1.839M |
| August 31, 2026 | 1.939M |
| August 28, 2026 | 1.906M |
| August 27, 2026 | 2.108M |
| August 26, 2026 | 2.088M |
| August 25, 2026 | 2.019M |
| August 24, 2026 | 1.975M |
| August 21, 2026 | 1.939M |
| August 20, 2026 | 2.007M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Supermax Corp. Bhd. | 454.69M |
| YD Bio Ltd. | -- |
| ALPS Group, Inc. | -- |
| Cencora, Inc. | 72.12B |
| ACADIA Pharmaceuticals, Inc. | 2.691B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.405M |
| Revenue (Quarterly) | 0.336M |
| Total Expenses (Quarterly) | 0.741M |
| EPS Diluted (Quarterly) | -0.0759 |
| Gross Profit Margin (Quarterly) | 23.51% |
| Profit Margin (Quarterly) | -120.5% |
| Earnings Yield | -434.5% |
| Normalized Earnings Yield | -434.45 |